Shock Clinical Trial - Hemodynamic Instability Index: The Impact to Care

Status Terminated

Clinical Trial Summary

Philips has developed a new algorithm, called Hemodynamic Instability Rules Based Advisor (HIRBA 2.0) system, for the prediction of hemodynamic instability in critically ill patients, who were not previously known to be at risk. This algorithm provides with the numerical index - Hemodynamic Instability Index (HII) and its trend which are calculated from existing real time data derived from patient's current hospital stay such as heart rate and blood pressure, labs, and Admission - Discharge- Transfer (ADT) data to help healthcare providers obtain information about patient's status and make clinical decisions.

The aim of the study is to determine if the patient clinical information, displayed in the form of HII, can prompt possible patient hemodynamic status change and trigger earlier clinical care team response. We hypothesize that this real-time information on hemodynamic instability and earlier clinical decision making will lead to reduced length of stay (LOS) and ICU mortality relative to standard care practice. Study will also identify if the use of the Philips new algorithm called Hemodynamic Instability Rules Based Advisor (HIRBA 2.0) can improve outcomes for patients admitted to the intensive care units (ICUs).

During this study, upon patient admission to the ICU clinical data collection will begin. Data that will be pulled during the study includes: vital signs, medications, reason for admission to the ICU, treatments that patient may receive.

Research subjects will not be asked to do anything as far as specific activities expected to be accomplished during study participation. Subjects will be involved in the study only during their stay in ICU. HII information will be visible to clinicians, taking care of this patient only during his/ her stay in the study unit.

Study team will collect patient information and have the ability to view the HII for subjects.

Once patient leaves the ICU the study team will collect information on the remainder of patient's hospital course including date of hospital discharge. All collected data will be then fully de-identified and released to Philips for analysis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02185521
Study type	Interventional
Source	Philips Healthcare
Contact
Status	Terminated
Phase	N/A
Start date	March 1, 2016
Completion date	November 18, 2016

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05898126` - Renin-guided Hemodynamic Management in Patients With Shock	N/A
Completed	`NCT05563701` - Evaluation of the LVivo Image Quality Scoring (IQS)
Recruiting	`NCT05066256` - LV Diastolic Function vs IVC Diameter Variation as Predictor of Fluid Responsiveness in Shock	N/A
Not yet recruiting	`NCT06285513` - Cardiovascular Metabolic Remodeling in Shock
Not yet recruiting	`NCT05649891` - Checklists Resuscitation Emergency Department	N/A
Terminated	`NCT02755155` - Optimization of Therapeutic Human Serum Albumin Infusion in Selected Critically Ill Patients	Phase 4
Not yet recruiting	`NCT01941472` - Transcutaneous pO2, Transcutaneous pCO2 and Central Venous pO2 Variations to Predict Fluid Responsiveness	N/A
Terminated	`NCT01696175` - PICU Admission Lactate and Central Venous Oxymetry Study	N/A
Completed	`NCT01680783` - Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure	N/A
Recruiting	`NCT01157299` - Hemodynamic Evaluation of Preload Responsiveness in Children by Using PiCCO	N/A
Recruiting	`NCT01174966` - Assessment of Transcutaneous Oxygen Tension/Oxygen Challenge Test in Intensive Care Unit (ICU) Patients	N/A
Completed	`NCT00743522` - Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention Indication
Completed	`NCT03296891` - Point of Care Ultrasonography In The Management of Shock: A Pilot Study	N/A
Recruiting	`NCT05922982` - Norepinephrine Weaning Guided by the Hypotension Prediction Index in Vasoplegic Shock After Cardiac Surgery	N/A
Withdrawn	`NCT04705701` - Comparing Post Cardiac Surgery Outcomes in ESRD Patient's With Early Dialysis Versus Standard Care	N/A
Recruiting	`NCT04615065` - Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Completed	`NCT05330676` - Evaluation of Microcirculatory Function and Mitochondrial Respiration After Cardiovascular Surgery
Active, not recruiting	`NCT04079829` - Postoperative Respiratory Abnormalities
Completed	`NCT04089098` - VOLume and Vasopressor Therapy in Patients With Hemodynamic instAbility
Completed	`NCT03190408` - Variation in Fluids Administered in Shock

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Hemodynamic Instability Index: The Impact to Care With a New Predictive Indicator — HII

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms